• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity.LASS5与SDHB相互作用并协同抑制p53和p21的活性。
Curr Mol Med. 2016;16(6):582-90. doi: 10.2174/1566524016666160607090012.
2
Synergistic efficacy of LBH and alphaB-crystallin through inhibiting transcriptional activities of p53 and p21.通过抑制 p53 和 p21 的转录活性,LBH 与 αB-晶状体蛋白发挥协同疗效。
BMB Rep. 2010 Jun;43(6):432-7. doi: 10.5483/bmbrep.2010.43.6.432.
3
Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.在HeLa细胞中,Zac1通过拮抗调节因子p53和组蛋白去乙酰化酶1对细胞周期蛋白依赖性激酶抑制剂p21(WAF1/Cip1)基因进行调控。
Mol Cancer Res. 2008 Jul;6(7):1204-14. doi: 10.1158/1541-7786.MCR-08-0123.
4
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.Survivin、CDC25C和PLK1基因的间接p53依赖性转录抑制需要细胞周期蛋白依赖性激酶抑制剂p21/CDKN1A以及与DREAM复合物结合的CDE/CHR启动子位点。
Oncotarget. 2015 Dec 8;6(39):41402-17. doi: 10.18632/oncotarget.6356.
5
Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.p53-DDX3 通路改变导致的 p21(WAF1/CIP1) 减少与早期人乳头瘤病毒相关肺癌的无复发生存不良相关。
Clin Cancer Res. 2011 Apr 1;17(7):1895-905. doi: 10.1158/1078-0432.CCR-10-2316. Epub 2011 Feb 16.
6
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.PBK/TOPK 与肿瘤抑制因子 p53 的 DBD 结构域相互作用,并调节包括 p21 在内的转录靶标表达。
Oncogene. 2010 Oct 7;29(40):5464-74. doi: 10.1038/onc.2010.275. Epub 2010 Jul 12.
7
ING1 represses transcription by direct DNA binding and through effects on p53.ING1 通过直接结合 DNA 以及对 p53 的作用来抑制转录。
Cancer Res. 2003 Sep 15;63(18):5785-92.
8
Mammalian Lass6 and its related family members regulate synthesis of specific ceramides.哺乳动物的Lass6及其相关家族成员调节特定神经酰胺的合成。
Biochem J. 2005 Aug 15;390(Pt 1):263-71. doi: 10.1042/BJ20050291.
9
LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor.LASS5是一种真正的二氢神经酰胺合酶,它选择性地利用棕榈酰辅酶A作为酰基供体。
J Biol Chem. 2005 Oct 7;280(40):33735-8. doi: 10.1074/jbc.M506485200. Epub 2005 Aug 12.
10
The impact of R213 mutation on p53-mediated p21 activity.R213 突变对 p53 介导的 p21 活性的影响。
Biochimie. 2014 Apr;99:215-8. doi: 10.1016/j.biochi.2013.12.017. Epub 2013 Dec 30.

引用本文的文献

1
Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells.靶向细胞神经酰胺代谢以增强癌细胞凋亡的天然产物和小分子
Cancers (Basel). 2023 Sep 20;15(18):4645. doi: 10.3390/cancers15184645.
2
High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer.神经酰胺合酶5的高表达预示着胃癌的预后不良。
Transl Cancer Res. 2022 Sep;11(9):3209-3221. doi: 10.21037/tcr-22-1348.
3
Astrocytic ceramide as possible indicator of neuroinflammation.星形胶质细胞神经酰胺可能作为神经炎症的标志物。
J Neuroinflammation. 2019 Feb 25;16(1):48. doi: 10.1186/s12974-019-1436-1.
4
C-ceramide is a natural regulatory ligand of p53 in cellular stress response.C-神经酰胺是细胞应激反应中 p53 的天然调节配体。
Nat Commun. 2018 Oct 8;9(1):4149. doi: 10.1038/s41467-018-06650-y.

本文引用的文献

1
The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.p53在肿瘤起始和进展中的细胞周期阻滞及凋亡功能
Cold Spring Harb Perspect Med. 2016 Mar 1;6(3):a026104. doi: 10.1101/cshperspect.a026104.
2
Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma.琥珀酸脱氢酶亚基B的下调和丙酮酸脱氢酶激酶1的上调预示复发性鼻咽癌预后不良。
Tumour Biol. 2016 Apr;37(4):5145-52. doi: 10.1007/s13277-015-4107-6. Epub 2015 Nov 7.
3
Development of pheochromocytoma in ceramide synthase 2 null mice.神经酰胺合酶2基因敲除小鼠嗜铬细胞瘤的发生
Endocr Relat Cancer. 2015 Aug;22(4):623-32. doi: 10.1530/ERC-15-0058. Epub 2015 Jun 25.
4
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.结直肠癌患者体内的内源性大麻素和神经酰胺水平会发生改变。
Oncol Rep. 2015 Jul;34(1):447-54. doi: 10.3892/or.2015.3973. Epub 2015 May 12.
5
Structural and functional consequences of succinate dehydrogenase subunit B mutations.琥珀酸脱氢酶亚基B突变的结构和功能后果
Endocr Relat Cancer. 2015 Jun;22(3):387-97. doi: 10.1530/ERC-15-0099.
6
Linking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancers.将神经酰胺合酶(CerSs)4和5与细胞凋亡、子宫内膜癌和结肠癌联系起来。
Exp Mol Pathol. 2015 Jun;98(3):585-92. doi: 10.1016/j.yexmp.2015.03.019. Epub 2015 Mar 13.
7
Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.琥珀酸脱氢酶亚基B在体外抑制人卵巢癌中的AMPK-HIF-1α通路。
J Ovarian Res. 2014 Dec 10;7:115. doi: 10.1186/s13048-014-0115-1.
8
Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review.散发性嗜铬细胞瘤/副神经节瘤种系突变检测:一项系统评价
Clin Endocrinol (Oxf). 2015 Mar;82(3):338-45. doi: 10.1111/cen.12530. Epub 2014 Jul 7.
9
Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.核糖核苷酸还原酶金属辅因子:组装、维持与抑制
Front Biol (Beijing). 2014 Jan 2;9(2):104-113. doi: 10.1007/s11515-014-1302-6.
10
Reduced succinate dehydrogenase B expression is associated with growth and de-differentiation of colorectal cancer cells.琥珀酸脱氢酶B表达降低与结肠癌细胞的生长和去分化相关。
Tumour Biol. 2013 Aug;34(4):2337-47. doi: 10.1007/s13277-013-0781-4. Epub 2013 May 5.

LASS5与SDHB相互作用并协同抑制p53和p21的活性。

LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity.

作者信息

Jiang Z, Li F, Wan Y, Han Z, Yuan W, Cao L, Deng Y, Peng X, Chen F, Fan X, Liu X, Dai G, Wang Y, Zeng Q, Shi Y, Zhou Z, Chen Y, Xu W, Luo S, Chen S, Ye X, Mo X, Wu X, Li Y

机构信息

The Center for Heart Development, Hunan Normal University, Changsha 410081, Hunan, P.R. China.

出版信息

Curr Mol Med. 2016;16(6):582-90. doi: 10.2174/1566524016666160607090012.

DOI:10.2174/1566524016666160607090012
PMID:27280497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5280074/
Abstract

Longevity Assurance 5 (LASS5), a member of the LASS/Ceramide Synthases family, synthesizes C16-ceramide and is implicated in tumor biology. However, its precise role is not yet well understood. A yeast two-hybrid screen was performed using a human cDNA library to identify potential LASS5- interaction partners. One identified clone encodes succinate dehydrogenase subunit B (SDHB). Mammalian two-hybrid assays showed that LASS5 interacts with SDHB, and the result was also confirmed by GST pull-down and coimmunoprecipitation assays. The C-terminal fragment of SDHB was required for the interaction. LASS5 and SDHB were co-localized in COS-7 cells. LASS5 and SDHB expressions were found to be up-regulated in neuroglioma tissue. Transfection assays showed that LASS5 or SDHB expression repressed p53 or p21 reporter activity, respectively. Simultaneous LASS5 and SDHB expression resulted in stronger repression of p53 and p21 reporter activity, suggesting that LASS5 and SDHB interaction may synergistically affect transcriptional regulation of p53 and p21. Our data provide new molecular insights into potential roles of LASS5 and SDHB in tumor biology.

摘要

长寿保障蛋白5(LASS5)是LASS/神经酰胺合酶家族的成员之一,可合成C16 - 神经酰胺,并与肿瘤生物学相关。然而,其确切作用尚未完全明确。利用人cDNA文库进行酵母双杂交筛选,以鉴定潜在的LASS5相互作用伙伴。一个鉴定出的克隆编码琥珀酸脱氢酶亚基B(SDHB)。哺乳动物双杂交试验表明LASS5与SDHB相互作用,并且该结果也通过谷胱甘肽 - S - 转移酶(GST)下拉试验和免疫共沉淀试验得到证实。SDHB的C末端片段是相互作用所必需的。LASS5和SDHB在COS - 7细胞中共定位。研究发现LASS5和SDHB在神经胶质瘤组织中表达上调。转染试验表明,LASS5或SDHB的表达分别抑制p53或p21报告基因的活性。同时表达LASS5和SDHB会导致对p53和p21报告基因活性更强的抑制,这表明LASS5和SDHB的相互作用可能协同影响p53和p21的转录调控。我们的数据为LASS5和SDHB在肿瘤生物学中的潜在作用提供了新的分子见解。